Moneycontrol PRO
Upcoming Webinar:Prashant Shah explains ‘Irrelevance of Bull & Bear Markets for Success in Technical Analysis’. Register For Free!
you are here: HomeNewsBusiness

India opposes WTO’s binding commitments for faster trade clearances: Report

This comes after Brazil, Columbia, Japan and the United States argued for speed because “trade is a critical channel for getting essential products to those in need"

October 23, 2020 / 11:04 AM IST
Trade (Image: Reuters)

Trade (Image: Reuters)


India has opposed binding commitments for faster clearances of cross-border merchandise by the World Trade Organisation (WTO), stating it has already implemented several commitments under the global trade facilitation agreement (TFA).

“New Delhi told the WTO that countries should not be saddled with binding commitments,” a Geneva-based official told The Economic Times.

Moneycontrol could not independently verify the report.

This comes after Brazil, Columbia, Japan and the United States argued for speed because “trade is a critical channel for getting essential products to those in need,” the report said.

India also informed these members that more than 73 percent of its TFA commitments were put into place and implemented ahead of schedule, it added.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Follow our LIVE Updates on the coronavirus pandemic here

Welcoming India's implementation of improved transparency in customs practices and allowing the processing of goods before arrival, the US responded that these will have “immediate impact” on traders, the official added.

They said that the US acknowledged India as an example of how the TFA helps traders respond to the pandemic.

Part of the WTO’s 2013 Bali package, this agreement seeks to reduce the cost of global trade by over a trillion dollars. It covers provisions such as advance rulings, customs cooperation, import-export of goods and information sharing.

Follow our full COVID-19 coverage here
Moneycontrol News
first published: Oct 23, 2020 11:04 am

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark